Elicera Therapeutics AB Financial Overview
Elicera Therapeutics AB's market cap is currently €24.28M. The company's EPS TTM is €0.0005442; its P/E ratio is -15.51; Elicera Therapeutics AB is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
